Syra Health Corp
corporate_fare Company Profile
Syra Health Corp (OTC:SYRA) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 13 items for SYRA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-11, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for SYRA spans 10-Q, 8-K, DEFA14A, DEF 14A.
Recent high-impact activity:
- Syra Health Delivers a Second Straight Profitable Quarter but Warns Its Survival Is at Risk
- Syra Health Posts Second Straight Profitable Quarter, Revenue Up 23%
- Syra Health Seeks Shareholder Approval for 34% Equity Incentive Plan Increase
- Syra Health Seeks Shareholder Approval for Significant Equity Plan Expansion
- Syra Health Reports First Profitable Quarter in Q1 2026 with Strong Revenue Growth and Improved Margins
Financial Snapshot
Short Interest & Short Volume
5.12 days to coverFINRA reported short interest of 447,723 shares in SYRA as of the September 15, 2026 settlement, a 16.5% increase from the prior period — about 5.1 days to cover at its recent average daily volume. On October 2, 2026, 13.6% of SYRA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for SYRA, detected from its recent SEC filings.
Resale Registration for Series B Warrants · Warrant Terms
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →